Titan Pharma (TTNP)

Nov 27, 2024, 4:05 PM EST - 7 weeks ago

Titan Pharmaceuticals, Inc. Announces Receipt of Notice from Nasdaq

Aug 22, 2024, 11:21 AM EDT - 5 months ago

TITAN PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Titan Pharmaceuticals, Inc. - TTNP

Aug 19, 2024, 4:11 PM EDT - 5 months ago

Titan Pharmaceuticals Enters Into Merger Agreement With KE Sdn. Bhd.

Jan 25, 2024, 4:29 PM EST - 1 year ago

Titan Pharmaceuticals Fully Compliant With NASDAQ Listing Criteria

Dec 28, 2023, 4:15 PM EST - 1 year ago

Titan Pharmaceuticals Announces Reverse Stock Split and Ratio

Oct 16, 2023, 4:37 PM EDT - 1 year ago

Titan Pharmaceuticals Announces Appointment of Dato' Seow Gim Shen and Brynner Chaim to the Company's Board of Directors

Sep 18, 2023, 7:30 AM EDT - 1 year ago

Titan Pharmaceuticals Announces $9.5 Million Private Placement of Convertible Preferred Stock

Jul 27, 2023, 7:30 AM EDT - 1 year ago

Titan Pharmaceuticals Announces Sale of Certain ProNeura Assets

Dec 15, 2022, 7:00 AM EST - 2 years ago

Titan Pharmaceuticals Provides Shareholder Update

Dec 12, 2022, 7:49 AM EST - 2 years ago

UPDATE -- Titan Pharmaceuticals Inc. Announces Licensing Agreement with Ocular Therapeutix Inc.

Aug 16, 2022, 10:53 AM EDT - 2 years ago

Titan Pharmaceuticals Announces Board Expansion and Management Changes

Jul 5, 2022, 8:00 AM EDT - 2 years ago

Titan Pharmaceuticals Announces FDA Clearance of IND Application for Nalmefene Implant

Jun 10, 2022, 8:00 AM EDT - 2 years ago

Activist Investing Discloses 9.9% Ownership Interest in Titan Pharmaceuticals, Inc.

Apr 25, 2022, 1:29 PM EDT - 2 years ago

Activist Investing Announces 5.6% Ownership Interest in Titan Pharmaceuticals, Inc.

Feb 2, 2022, 12:27 PM EST - 3 years ago

Titan Pharmaceuticals Raises $5.5M Via Equity

Feb 2, 2022, 8:45 AM EST - 3 years ago

Titan Pharmaceuticals Announces Pricing of $5.5 Million Registered Direct and PIPE Offering Priced At-The-Market

Dec 21, 2021, 8:00 AM EST - 3 years ago

Titan Pharmaceuticals to Explore Strategic Alternatives

Nov 8, 2021, 4:15 PM EST - 3 years ago

Sustained Anti-Pruritic Effect Of Titan's TP-2021 Implant Reported Today At Neuroscience 2021

Nov 5, 2021, 4:30 PM EDT - 3 years ago

Titan Announces Upcoming TP-2021 Implant Data Presentation at Neuroscience 2021

Oct 25, 2021, 7:15 AM EDT - 3 years ago

Titan Pharmaceuticals Receives Funding to Develop Combination HIV Therapeutic and Contraceptive Implant for Women in Developing Countries

Oct 12, 2021, 8:00 AM EDT - 3 years ago

Titan Pharmaceuticals and MUSC FRD Enter Into Research and Option License Agreement

Jun 23, 2021, 8:00 AM EDT - 3 years ago

Titan Announces Positive Results from the First Studies of TP-2021 Implant in an Established Animal Model of Chronic Pruritus

Mar 31, 2021, 4:30 PM EDT - 4 years ago

Titan Pharmaceuticals Announces Filing Of 2020 Annual Report On Form 10-K

Feb 1, 2021, 7:30 AM EST - 4 years ago

Positive Early Study Results Help Pave Wave for Titan Pharmaceuticals to Move Forward with its JT-09 ProNeura® Development Program

Jan 15, 2021, 9:15 AM EST - 4 years ago

Titan Pharmaceuticals Announces Pricing of $9.7 Million Registered Direct Offering

Nov 30, 2020, 12:50 PM EST - 4 years ago

Titan Pharmaceuticals Announces Reverse Stock Split

Nov 16, 2020, 8:45 AM EST - 4 years ago

Titan Pharmaceuticals Reports Third Quarter 2020 Financial Results

Oct 28, 2020, 3:00 PM EDT - 4 years ago

Titan Pharmaceuticals Announces Pricing of $8.0 Million Underwritten Public Offering

Oct 26, 2020, 6:30 AM EDT - 4 years ago

Titan Pharmaceuticals Announces Debt Settlement Agreement with Molteni and Horizon

Sep 18, 2020, 4:45 PM EDT - 4 years ago

Titan Pharmaceuticals' Stockholders Approve Proposal To Amend Its Certificate Of Incorporation

Sep 14, 2020, 8:30 AM EDT - 4 years ago

Titan Pharmaceuticals Provides Update To Stockholders On Proposal To Amend Its Certificate Of Incorporation

Aug 14, 2020, 7:08 PM EDT - 4 years ago

Titan Pharmaceuticals, Inc. (TTNP) CEO Sunil Bhonsle on Q2 2020 Results - Earnings Call Transcript

Aug 14, 2020, 8:45 AM EDT - 4 years ago

Titan Pharmaceuticals Reports Second Quarter 2020 Financial Results

Aug 10, 2020, 4:30 PM EDT - 4 years ago

Titan Pharmaceuticals To Report Second Quarter 2020 Financial Results On August 14, 2020

Jul 8, 2020, 8:00 AM EDT - 4 years ago

Titan Pharmaceuticals Urges Stockholders to Vote "FOR" Proposal to Amend Its Certificate of Incorporation

Jun 24, 2020, 8:00 AM EDT - 4 years ago

Titan Pharmaceuticals And Indegene Enter Into Probuphine® Co-Promotion Partnership

May 15, 2020, 8:30 PM EDT - 5 years ago

Titan Pharmaceuticals, Inc. (TTNP) CEO Sunil Bhonsle on Q1 2020 Results - Earnings Call Transcript

May 15, 2020, 8:45 AM EDT - 5 years ago

Titan Pharmaceuticals Reports First Quarter 2020 Financial Results

Mar 31, 2020, 12:43 PM EDT - 5 years ago

Penny Stocks to Buy Using Technical Analysis for April 2020

CPIX OSG

Mar 30, 2020, 7:43 PM EDT - 5 years ago

Titan Pharmaceuticals, Inc. (TTNP) CEO Sunil Bhonsle on Q4 2019 Results - Earnings Call Transcript

Nov 14, 2019, 10:16 PM EST - 5 years ago

Titan Pharmaceuticals, Inc. (TTNP) CEO Sunil Bhonsle on Q3 2019 Results - Earnings Call Transcript

Aug 14, 2019, 10:19 PM EDT - 5 years ago

Titan Pharmaceuticals, Inc. (TTNP) CEO Sunil Bhonsle on Q2 2019 Results - Earnings Call Transcript

Aug 14, 2019, 7:32 AM EDT - 5 years ago

Q2 Earnings Preview For Titan Pharmaceuticals

May 15, 2019, 9:56 PM EDT - 6 years ago

Titan Pharmaceuticals, Inc. (TTNP) CEO Sunil Bhonsle on Q1 2019 Results - Earnings Call Transcript

Apr 2, 2019, 12:50 PM EDT - 6 years ago

Titan Pharmaceuticals, Inc. (TTNP) CEO Sunil Bhonsle on Q4 2018 Results - Earnings Call Transcript